Results 101 to 110 of about 18,157 (223)

P267: TSC1/TSC2 mosaicism is found in ∼13% of individuals with tuberous sclerosis and is associated with a distinctive phenotypic severity [PDF]

open access: diamond, 2023
Angela Peron   +23 more
openalex   +1 more source

microRNA-19a protects osteoblasts from dexamethasone via targeting TSC1

open access: yesOncotarget, 2017
Activation of mTOR complex 1 (mTORC1) could protect human osteoblasts from dexamethasone. Tuberous sclerosis complex 1 (TSC1) is mTORC1 upstream inhibitory protein. We demonstrate here that microRNA-19a ("miR-19a", -3p) targets the 3' untranslated regions of TSC1 mRNA.
Liu, Gang   +5 more
openaire   +3 more sources

Identifying a Recurrent BRCA1 Variant in the Qatari Population With Unique Genotype—Phenotype Correlations

open access: yesMolecular Genetics &Genomic Medicine, Volume 14, Issue 1, January 2026.
In this paper, we describe a common recurrent founder variant in the BRCA gene that was observed in the native Qatari population among high‐risk individuals seen in the cancer genetic clinic at the National Center for Cancer Care and Research. BRCA gene is associated with Hereditary breast and ovarian cancer syndrome (HBOC); it is very common in Qatar ...
Salha Bujassoum Al‐Bader   +9 more
wiley   +1 more source

TSC1 and DEPDC5 regulate HIV-1 latency through the mTOR signaling pathway [PDF]

open access: gold, 2018
Shan Jin   +7 more
openalex   +1 more source

Whole Exome Sequencing in Patients With Developmental Delay/Intellectual Disability (DD/ID), Epilepsy and the First Turkish Patient Diagnosed With BCL11A‐Related Intellectual Disability

open access: yesMolecular Genetics &Genomic Medicine, Volume 14, Issue 1, January 2026.
In this study, WES analysis was performed on patients with DD/ID, global developmental delay, epilepsy, and multiple congenital anomalies who could not be diagnosed through karyotype, CMA, and other examinations. Nineteen pathogenic/likely pathogenic (P/LP) variants were identified in 19 patients, and with the confirmation made in the parents and ...
Nejmiye Akkus   +5 more
wiley   +1 more source

Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for genotype-phenotype correlation [PDF]

open access: bronze, 1999
Marjon van Slegtenhorst   +10 more
openalex   +1 more source

Hemangioblastoma of the Kidney—A Comprehensive Clinical, Pathological, and Genetic Analysis of Four Cases

open access: yesAPMIS, Volume 134, Issue 1, January 2026.
ABSTRACT Hemangioblastoma (HB) is a benign central nervous system (CNS) tumor associated with mutations in the von Hippel–Lindau (VHL) gene. Although rare outside the CNS, the pathological and genetic features remain poorly understood. We analyzed four renal hemangioblastomas (RHB). Demographics, clinical presentation, and follow‐up data were collected.
Boglárka Pósfai   +17 more
wiley   +1 more source

Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex [PDF]

open access: diamond, 2004
James Brugarolas   +8 more
openalex   +1 more source

Pharmacotherapy Risks in Rare Genetic Diseases: Cross‐Referencing ACMG Secondary Findings v3.2 List With Clinical Databases

open access: yesClinical and Translational Science, Volume 19, Issue 1, January 2026.
ABSTRACT Clinical genomics and pharmacogenomics have largely remained separate fields, though some genetic variants have overlapping disease risk and drug implications. However, the extent of this overlap is not well studied. To explore this gap, we cross‐referenced genes from the American College of Medical Genetics Secondary Findings v3.2 list with ...
Josiah D. Allen   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy